17
Hypersensitivity Reactions Gell and Coombs classification: – Type I – IgE mediated (allergy) – Type II – Antibody-mediated cytotoxic – Type III – Immune Complex mediated – Type IV – Delayed-Type Hypersensitivity (DTH) Types I, II and III are “immediate” Type IV is delayed

Gell and Coombs classification - Semantic Scholar · 2017. 10. 27. · – Serum sickness (following treatment with antiserum to a toxin) – Autoimmune diseases • SLE • Rheumatoid

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • Hypersensitivity Reactions

    • Gell and Coombs classification:– Type I – IgE mediated (allergy)– Type II – Antibody-mediated cytotoxic– Type III – Immune Complex mediated– Type IV – Delayed-Type Hypersensitivity

    (DTH)• Types I, II and III are “immediate”• Type IV is delayed

  • Type I Hypersensitivity

    • Antigens are called “allergens”• Unknown why people get allergies, but there is a

    strong genetic predisposition (called atopy)• Hallmark is inappropriate production of IgE

    against allergens that cause mast cell degranulation (see fig 15-2)

    • Normally IgE/mast cell activity should be directed against parasitic infections

  • Type I Hypersensitivity

    • Mediators of Type I hypersensitivites– Mast cell granule contents (early effects)

    • Histamine and Heparin - ↑ vascular permeability, smooth muscle contraction (intestines, bronchi), mucus secretion

    • Chemotactic factors – attract eosinophils and neutrophils• Proteases – mucus secretion, complement activation,

    degradation of blood vessel basement membrane

    – Later Effects• Leukotrienes and prostaglandins – secreted after tissue

    disruption caused by mast cell degranulation, effects are similar to histamine

    • Arrival of proinflammatory eosinophils and neutrophils

  • Clinical Manifestations of Type I• Systemic anaphylaxis

    – Allergen gets into the blood stream– Dyspnea, ↓BP, bronchole constriction, GI and bladder

    smooth muscle contration, shock, death within minutes if untreated

    – Treatment - epinephrine• Allergic rhinitis (hay fever)

    – Inhaled allergen triggers reaction in nasal mucosa– Watery exudate from nose, eyes, upper respiratory

    tract, sneeezing and coughing

  • Clinical Manifestations of Type I• Asthma

    – Allergic asthma – due to inhaled airborne allergens (pollens, dust, fumes, etc)

    – Intrinsic asthma – triggered by cold, exercise– Reaction develops in lower respiratory tract– Bronchoconstriction, airway edema, mucus secretion,

    inflammation• Food allergies

    – Ingestion of allergen– Vomiting and diarrhea– If allergens are absorbed into bloodstream, reactions can occur

    where allergen deposits• asthma-like symptoms• Urticaria (hives, wheal & flare response)

  • Clinical Manifestations of Type I

    • Atopic Dermatitis (allergic eczema)– Often occurs in young children– Red skin rash– Strong hereditary predisposition

  • Type I Hypersensitivity• Skin testing

    – Potential allergens are injected or scratched into the skin

    – If the patient is allergic a wheal & flare response occurs

    • RIST –radioimmunosorbent test – similar to RIA, non-invasive way to identify allergies

  • Type I Hypersensitivity

    • Treatment– Avoid allergen if possible– Antihistamines, or anti-prostaglandins– Hyposensitization – injections of low doses of

    allergen may cause a shift from IgE to IgG as the dominant antibody formed.

  • Type II Hypersensitivity

    • Antibody-mediated Cytotoxic HS– Antibodies (IgM or IgG) bind to cell surface

    antigens. Antigen/antibody complex may lead to:

    • Complement activation lysis• ADCC• Opsonization phagocytosis

    – These are normal reactions, but when they cause unwarranted tissue damage, they are considered a hypersensitivity.

  • Type II Hypersensitivity

    • Examples of Type II HS:– Transfusion reactions

    • To ABO blood groups• To other RBC blood groups

    – Hemolytic disease of the newborn (erythroblastosis fetalis)

    – Drug-induced hemolytic anemia (penicillin)

  • Type III Hypersensitivity

    • Immune Complex Disease– Antibody (IgG) / attaching to soluble antigen

    leads to complex formation– Immune complexes may deposit in:

    • Blood vessel walls (vasculitis)• Synovial joints (arthritis)• Glomerular basement membrane

    (glomerulonephritis)• Choroid plexus

  • Type III Hypersensitivity• Damage occurs due to:

    – Anaphylatoxin release due to complement activation (C3a, C5a) which then attracts neutrophils, and causes mast cell degranulation

    – Neutrophils have trouble phagocytosing “stuck” immune complexes so they release their granule contents leading to more inflammation

    – Platelet aggregation also results from complement activation

    • These effects are also known as the Arthus reaction

  • Type III Hypersensitivity

    • Localized reactions– edema and redness (erythema) and tissue

    necrosis of the affected tissue– Can occur in the skin following insect bites– Can occur in the lungs

    • E.g. “farmer’s lung” from inhaling particles from moldy hay

  • Type III Hypersenstivity

    • Generalized reactions:– Serum sickness (following treatment with

    antiserum to a toxin)– Autoimmune diseases

    • SLE• Rheumatoid arthritis

    – Drug reactions (penicillin)– Infectious diseases

    • Meningitis, hepatitis, malaria, mono etc.

  • Type IV Hypersensitivity

    • Delayed type hypersensitivity (DTH)– TH cells that have been “sensitized” by an antigen

    develop a TH1 and (sometimes a TC response) leading to macrophage recruitment and activation.

    – First noticed with reaction to tuberculosis bacteria (tuberculin reaction)

    – Hallmarks of type IV is the large number of macrophages at the reaction site, and that it takes an average of 24 hrs to manifest after repeat exposure.

  • Hypersensitivity ReactionsType I HypersensitivityType I HypersensitivitySlide Number 4Clinical Manifestations of Type IClinical Manifestations of Type IClinical Manifestations of Type IType I HypersensitivityType I HypersensitivityType II HypersensitivityType II HypersensitivityType III HypersensitivityType III HypersensitivityType III HypersensitivityType III HypersenstivityType IV HypersensitivitySlide Number 17